The Technical Analyst
Select Language :
NeuBase Therapeutics Inc [NBSE]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

NeuBase Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

NeuBase Therapeutics Inc is listed at the  Exchange

4.58% $0.450

America/New_York / 28 mar 2024 @ 16:00


NeuBase Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 1.678 mill
EPS: -18.60
P/E: -0.0200
Earnings Date: Mar 28, 2024
SharesOutstanding: 3.73 mill
Avg Daily Volume: 0.242 mill
RATING 2024-03-28
A-
Buy
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Sell
Return On Asset: Neutral
DE: Strong Buy
P/E: Sell
Price To Book: Neutral
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.0200 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
0.00x
Company: PE -0.0200 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.356 - 0.532

( +/- 19.82%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2022-12-31 Symetryx Corp Buy 0
2023-09-14 Symetryx Corp Sell 129 108 Common Stock, Par Value $0.0001 per Share
2023-09-15 Symetryx Corp Sell 103 337 Common Stock, Par Value $0.0001 per Share
2023-09-18 Symetryx Corp Sell 50 000 Common Stock, Par Value $0.0001 per Share
2023-08-23 Symetryx Corp Sell 0 Common Stock, Par Value $0.0001 per Share
INSIDER POWER
-19.85
Last 87 transactions
Buy: 13 371 397 | Sell: 4 577 643

Forecast: 16:00 - $0.450

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $0.450
Forecast 2: 16:00 - $0.450
Forecast 3: 16:00 - $0.450
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.450 (4.58% )
Volume 0.282 mill
Avg. Vol. 0.242 mill
% of Avg. Vol 116.86 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for NeuBase Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for NeuBase Therapeutics Inc

RSI

Intraday RSI14 chart for NeuBase Therapeutics Inc

Last 10 Buy & Sell Signals For NBSE

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            NeuBase Therapeutics Inc

NBSE

NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its lead programs include NT0100, a PATrOL enabled anti-gene for Huntington's disease; NT0200, a PATrOL enabled anti-gene for myotonic dystrophy type 1; NT0300, a PATrOL-enabled therapeutic treatment to target the mutated KRAS gene. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.

Last 10 Buy Signals

Date Signal @
SUIUSDMar 29 - 11:301.950
RBTCUSDMar 29 - 11:31$69 750
HNTUSDMar 29 - 11:33$6.28
GTCUSDMar 29 - 11:332.28
NANOUSDMar 29 - 11:30$1.647
ICPUSDMar 29 - 11:33$17.48
FILUSDMar 29 - 11:33$9.93
BALUSDMar 29 - 11:32$5.11
CVCUSDMar 29 - 11:32$0.208
MINAUSDMar 29 - 11:30$1.230

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.